Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Vical, Inc.

Vical researches and develops biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in which the expressed protein is an immunogen, cancer immunotherapeutics, in which the expressed protein is an immune system stimulant and cardiovascular therapies, in which the expressed protein is an angiogenic growth factor.

Search Projects

  • Chief Operating Officer
  • Vice President, Research
  • Executive Director, Functional Genomics
  • Executive Director, Clinical Research
  • Director, Medical Affairs
  • Medical Director
  • Director, Clinical Affairs
  • Director, Clinical Research Operations
  • Executive Director, Clinical Research